-
- Victor Araujo Correa
- Adolfo Lutz Institute, Immunology Center São Paulo São Paulo Brazil
-
- Amanda Izeli Portilho
- Adolfo Lutz Institute, Immunology Center São Paulo São Paulo Brazil
-
- Elizabeth De Gaspari
- Adolfo Lutz Institute, Immunology Center São Paulo São Paulo Brazil
説明
<jats:title>Abstract</jats:title><jats:p>Vaccines are the most effective tool to control infectious diseases, which provoke significant morbidity and mortality rates. Most vaccines are administered through the parenteral route and can elicit a robust systemic humoral response, but they induce a weak T‐cell‐mediated immunity and are poor inducers of mucosal protection. Considering that most pathogens enter the body through mucosal surfaces, a vaccine that elicits protection in the first site of contact between the host and the pathogen is promising. However, despite the advantages of mucosal vaccines as good options to confer protection on the mucosal surface, only a few mucosal vaccines are currently approved. In this review, we discuss the impact of vaccine administration in different mucosal surfaces; how appropriate adjuvants enhance the induction of protective mucosal immunity and other factors that can influence the mucosal immune response to vaccines.</jats:p>
収録刊行物
-
- Immunology
-
Immunology 167 (2), 124-138, 2022-07-12
Wiley